{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "14520135",
  "DateCompleted": {
    "Year": "2004",
    "Month": "01",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0271-0749",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "5",
        "PubDate": {
          "Year": "2003",
          "Month": "Oct"
        }
      },
      "Title": "Journal of clinical psychopharmacology",
      "ISOAbbreviation": "J Clin Psychopharmacol"
    },
    "ArticleTitle": "The effect of olanzapine on anxiety among patients with schizophrenia: preliminary findings.",
    "Pagination": {
      "StartPage": "523",
      "EndPage": "525",
      "MedlinePgn": "523-5"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Littrell",
        "ForeName": "Kimberly H",
        "Initials": "KH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Petty",
        "ForeName": "Richard G",
        "Initials": "RG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hilligoss",
        "ForeName": "Nicole M",
        "Initials": "NM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kirshner",
        "ForeName": "Carol D",
        "Initials": "CD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Johnson",
        "ForeName": "Craig G",
        "Initials": "CG"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Clin Psychopharmacol",
    "NlmUniqueID": "8109496",
    "ISSNLinking": "0271-0749"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "12794-10-4",
      "NameOfSubstance": "Benzodiazepines"
    },
    {
      "RegistryNumber": "3G0285N20N",
      "NameOfSubstance": "Pirenzepine"
    },
    {
      "RegistryNumber": "N7U69T4SZR",
      "NameOfSubstance": "Olanzapine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Benzodiazepines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Olanzapine"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Pirenzepine"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Schizophrenia"
    }
  ]
}